the new JN1 coronavirus variant: The World Health Organization is monitoring its rapid global spread

 The World Health Organization (WHO) has classified JN.1, an omicron variant of the coronavirus, as a “variant of concern.”


The spread of JN.1 has been confirmed in several countries around the world, including India, China, the United Kingdom, and the United States of America.

The World Health Organization (WHO) notes that the risk to people is currently low and can be prevented with current vaccines.

However, she warns that the new coronavirus and other infections may increase this winter.

Respiratory viruses such as influenza, respiratory syncytial virus (RSV), and pneumonia are increasing in children in the Northern Hemisphere.

The viruses that cause the new coronavirus constantly mutate over time, sometimes producing new strains.


The ami-corone strain has been the dominant strain worldwide for some time.


The World Health Organization is currently tracking a number of variants associated with the amikoron virus, including the JN1 strain, none of which are considered to be of concern.

 JN1 is rapidly spreading around the world


The new JN1 coronavirus variant

According to the US Centers for Disease Control and Prevention in the United States of America, this type is currently the most widespread in the United States, accounting for 15-29% of infections.

According to the UK's NHS, JN1 currently represents around 7% of positive Covid tests analyzed in laboratories.

The agency says it will continue to monitor all available data on this and

other strains of the virus.

Increased spread in winter

The JN1 virus is spreading rapidly in all regions, possibly due to more mutations in the spike protein than in the BA.2.86 strain from which the virus originated.


The risk assessment conducted by the World Health Organization states: “This variant is expected to cause an increase in infections with the emerging coronavirus (SARS-CoV-2), especially in countries entering the winter season, amid a rise in other viral and bacterial infections.”


The World Health Organization (WHO) has stated that there is limited evidence on the extent to which the JN1 virus can overcome vaccine immunity.


There are also no reports of more people becoming infected with JN1 than previous types.


However, the World Health Organization said more research is needed to understand the health impact, as the number of countries reporting data on people hospitalized with COVID-19 has fallen significantly.


    Font Size
    lines height